Dexcom Inc [NASDAQ: DXCM] stock went on an upward path that rose over 10197968% on Tuesday, amounting to a one-week price increase of more than 5.51%.
Over the last 12 months, DXCM stock rose by 12.60%. The one-year Dexcom Inc stock forecast points to a potential downside of -4015444.04. The average equity rating for DXCM stock is currently 1.47, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $34.34 billion, with 392.10 million shares outstanding and 386.48 million shares in the current float. Compared to the average trading volume of 4.03M shares, DXCM stock reached a trading volume of 10197968 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Dexcom Inc [DXCM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for DXCM shares is $100.36 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on DXCM stock is a recommendation set at 1.47. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Truist have made an estimate for Dexcom Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 16, 2025. While these analysts kept the previous recommendation, Goldman raised their target price to Buy. The new note on the price target was released on May 30, 2025, representing the official price target for Dexcom Inc stock. Previously, the target price had yet another raise to $85, while Mizuho analysts kept a Outperform rating on DXCM stock. On February 03, 2025, analysts increased their price target for DXCM shares from 85 to 115.
The Price to Book ratio for the last quarter was 15.15, with the Price to Cash per share for the same quarter was set at 6.89. Price to Free Cash Flow for DXCM in the course of the last twelve months was 59.70 with Quick ratio for the last quarter at 1.32.
DXCM Stock Performance Analysis:
Dexcom Inc [DXCM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.51. With this latest performance, DXCM shares gained by 3.23% in over the last four-week period, additionally plugging by 16.36% over the last 6 months – not to mention a rise of 12.60% in the past year of trading.
Insight into Dexcom Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Dexcom Inc [DXCM] shares currently have an operating margin of 15.25% and a Gross Margin at 59.43%. Dexcom Inc’s Net Margin is presently recorded at 12.90%.
Return on Equity for this stock inclined to 8.09%, with Return on Assets sitting at 8.09%.
DXCM Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for DXCM. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Dexcom Inc go to 23.98%.
Dexcom Inc [DXCM] Institutonal Ownership Details
There are presently around $97.23%, or 97.64% of DXCM stock, in the hands of institutional investors. The top three institutional holders of DXCM stocks are: VANGUARD GROUP INC with ownership of 46.51 million shares, which is approximately 11.6516%. BLACKROCK INC., holding 34.52 million shares of the stock with an approximate value of $$3.91 billion in DXCM stocks shares; and BLACKROCK INC., currently with $$1.85 billion in DXCM stock with ownership which is approximately 4.0853%.
